News article
$185 million investment to fast-track treatments for rare and ‘untreatable’ cancers
A private public partnership to strengthen Australia’s position at the forefront of the cancer treatment revolution The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub: building links from research through to the